Reaction
Implant Site Infection reporting signals
As of the last recalculation, Implant Site Infection appears in 2,231 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL (PRR 164.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Etonogestrel | 613 | 164.9 | 167.0 |
| Baclofen | 346 | 44.2 | 44.4 |
| Bupivacaine | 30 | 30.3 | 30.4 |
| Testosterone | 43 | 17.5 | 17.5 |
| Cefazolin | 13 | 13.4 | 13.4 |
| Rifampicin | 14 | 13.0 | 13.0 |
| Pyrazinamide | 12 | 12.0 | 12.0 |
| Cefazolin Sodium | 13 | 10.1 | 10.1 |
| Amphotericin B | 13 | 9.7 | 9.7 |
| Clonidine | 41 | 7.6 | 7.6 |
| Isoniazid | 11 | 6.4 | 6.4 |
| Hydromorphone Hydrochloride | 47 | 4.8 | 4.8 |
| Abemaciclib | 6 | 2.8 | 2.8 |